The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Avadel Pharmaceuticals plc shares valued at $39,640 were purchased by Palczuk Linda on Jan 21 ’25. At $7.93 per share, Palczuk Linda acquired 5,000 shares. The insider’s holdings grew to 67,900 shares worth approximately $0.6 million following the completion of this transaction.
Also, Thornton Peter J. purchased 10,000 shares, netting a total of over 80,450 in proceeds. Following the buying of shares at $8.04 each, the insider now holds 104,055 shares.
Before that, Ende Eric J had added 30,000 shares to its account. In a trade valued at $235,218, the Director bought Avadel Pharmaceuticals plc shares for $7.84 each. Upon closing the transaction, the insider’s holdings increased to 30,000 shares, worth approximately $1.86 million.
As published in their initiating research note from Deutsche Bank on February 11, 2025, Avadel Pharmaceuticals plc [AVDL] has been a Buy and the price target has been revised to $12. Analysts at Rodman & Renshaw started covering the stock with ‘”a Buy”‘ outlook in a report released in mid June. As of March 05, 2024, Oppenheimer has reiterated its “an Outperform” rating for AVDL. Earlier on March 05, 2024, Needham resumed its rating. Their recommendation was “a Buy” for AVDL stock.
Analyzing AVDL Stock Performance
During the last five days, there has been a surge of approximately 6.96%. Over the course of the year, Avadel Pharmaceuticals plc shares have dropped approximately -15.22%. Shares of the company reached a 52-week high of $11.52 on 01/03/25 and a 52-week low of $7.39 on 01/10/25. A 50-day SMA is recorded $9.37, while a 200-day SMA reached $13.48. Nevertheless, trading volume fell to 1.45 million shares from 2.85 million shares the previous day.
Support And Resistance Levels for Avadel Pharmaceuticals plc (AVDL)
According to the 24-hour chart, there is a support level at 8.69, which, if violated, would cause prices to drop to 8.48. In the upper region, resistance lies at 9.23. The next price resistance is at 9.56. RSI (Relative Strength Index) is 53.57 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.87, which suggests the price will decrease in the coming days. Percent R is at 22.16%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
Which companies own the most shares of Avadel Pharmaceuticals plc (AVDL)?
On March 05, 2024, H.C. Wainwright assigned a price target of “a Buy” to the stock and reiterated coverage with a $25.
